Pharmidex delighted to meet with US Congressional Representative Scott Peters
October 28, 2017

Pharmidex delighted to meet with Congressional Representative Scott Peters and a delegation of San Diego, California's top business, civic and academic leaders in London.

17 October 2017 Pharmidex was delighted to be invited to a reception with United States Congressional Representative Scott Peters and a delegation of San Diego, California's top business, civic and academic leaders in London.


With thriving respective tech scenes, growing biotech industries and home to some of the world's best universities, London and San Diego are privileged to be known as two of the world's "smartest cities". Pharmidex has had a long interest in California as our first out of UK business development office was based at Sorrento Valley in San Diego.


Times of San Diego (article)


San Diego Regional EDC (pdf)

We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
July 30, 2025
We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
July 28, 2025
We’re delighted to welcome Gabrielle Georgiou and Dr. Mohammed Ahmad from the University of Hertfordshire as they begin their first experience in a scientific CRO environment here at Pharmidex ! This partnership is an exciting step in fostering early-career scientific talent by offering hands-on exposure to real-world drug discovery and preclinical research. A big thank you to the University of Hertfordshire for partnering with us to support the next generation of innovators. We’re proud to play a role in shaping future leaders in science through meaningful, practical learning opportunities. 👩‍🔬 👨‍🔬 Welcome to the team, Gabrielle and Mohammed!
BATA Taste Aversion
July 24, 2025
At Pharmidex , we offer Brief Access Taste Aversion (BATA) testing, which is a behavioural assay that quantifies how test subjects respond to different compounds or formulations by measuring lick response and aversion. This helps identify: ✅ Bitter-tasting APIs ✅ Unpalatable excipients ✅ The success of taste-masking strategies ✅ Formulation-dependent compliance risks Get in touch if you’re developing oral formulations, paediatric drugs, or repurposing bitter APIs, this could be the data your IND package needs.
More Posts